In summary, anomalous MEK-dependent ERK1/2 activation in SSRBCs can contribute to the pathogenesis of SCD by potentially activating at least two significant cellular players of vasoocclusive events, SSRBC adhesion and SSRBC-induced activation of leukocytes. This evidence concerns the gene MAPK3 and Schnyder corneal dystrophy.